Mainz BioMed N.V. | WebDisclosure

Basculer en Français

10885	Companies
236934	Keywords
165822	Articles
127147	Press releases

Home
Companies
Mainz BioMed N.V.

PRESS RELEASE

published on 11/10/2025 at 14:01, 9 months 16 days ago

Mainz Biomed to Attend the 38th Annual Meeting of the Gastroenterological Working Group of Rhineland-Palatinate (GARPS)
Mainz Biomed N.V. to attend the 38th GARPS Annual Meeting in Germany to showcase its cancer detection solutions and strengthen partnerships with key opinion leaders in gastroenterology

ColoAlert Mainz Biomed Cancer Detection Gastroenterology 38th GARPS Annual Meeting
BRIEF

published on 10/15/2025 at 15:06, 10 months 11 days ago

Mainz Biomed participera au sommet Maxim Growth 2025 à New York

Investisseurs Mayence Biomed Détection Du Cancer Rencontres Individuelles Sommet Maxim Growth
BRIEF

published on 10/15/2025 at 15:06, 10 months 11 days ago

Mainz Biomed to Join 2025 Maxim Growth Summit in NYC

Investors One-on-one Meetings Mainz Biomed Cancer Detection Maxim Growth Summit
PRESS RELEASE

published on 10/15/2025 at 15:01, 10 months 11 days ago

Mainz Biomed to Attend 2025 Maxim Growth Summit
Mainz Biomed N.V. to attend 2025 Maxim Growth Summit, featuring industry leaders and discussions on various sectors. Company specializes in cancer early detection

Biotechnology Mainz Biomed Cancer Detection Industry Leaders 2025 Maxim Growth Summit
BRIEF

published on 10/08/2025 at 15:05, 10 months 18 days ago

Mainz Biomed obtient des résultats prometteurs dans une étude sur les biomarqueurs du cancer du pancréas

Étude De Faisabilité Mayence Biomed Cancer Du Pancréas DÉTECTION PRÉCOCE Étude Des Biomarqueurs
BRIEF

published on 10/08/2025 at 15:05, 10 months 18 days ago

Mainz Biomed Achieves Promising Results in Pancreatic Cancer Biomarker Study

Early Detection Feasibility Study Mainz Biomed Pancreatic Cancer Biomarker Study
PRESS RELEASE

published on 10/08/2025 at 15:00, 10 months 18 days ago

Mainz Biomed Reports Topline Results from Feasibility Study of Biomarker Panel in Pancreatic Cancer Project
Mainz Biomed reports positive topline results from feasibility study of biomarker panel for pancreatic cancer detection, achieving 100% sensitivity and 95% specificity. The study paves the way for a reliable, non-invasive screening test

Early Detection Feasibility Study Mainz Biomed Pancreatic Cancer Biomarker Panel
BRIEF

published on 09/30/2025 at 14:06, 10 months 26 days ago

Mainz Biomed présentera les avancées en matière de dépistage du cancer colorectal

Cancer Colorectal Mayence Biomed Diagnostics Basés Sur L'ARN Réunion De L'OME Étude EAArly DETECT
BRIEF

published on 09/30/2025 at 14:06, 10 months 26 days ago

Mainz Biomed to Showcase Colorectal Cancer Screening Advances

Mainz Biomed Colorectal Cancer RNA-based Diagnostics WEO Meeting EAArly DETECT Study
PRESS RELEASE

published on 09/30/2025 at 14:01, 10 months 26 days ago

Mainz Biomed to Present the Future of Colorectal Cancer Screening at WEO CRC Screening Committee Meeting
Mainz Biomed to present innovative colorectal cancer screening approach at WEO CRC Meeting. Dr. Lena Krammes will discuss RNA-based diagnostics findings for early cancer detection and prevention

Mainz Biomed Colorectal Cancer Screening RNA-based Diagnostics WEO CRC Meeting

Accesswire

Published on 08/26/2026 at 23:00, 13 minutes ago

Datametrex Announces Transition to Semi-Annual Financial Reporting
Published on 08/26/2026 at 22:30, 43 minutes ago

AI/ML Innovations Inc. Closes First Tranche of Private Placement
Published on 08/26/2026 at 22:30, 43 minutes ago

Blueberries Medical Announces Closing of C$1.1 Million Non-Brokered Private Placement
Published on 08/26/2026 at 21:15, 1 hour 58 minutes ago

Announces Private Placement of Convertible Promissory Notes
Published on 08/26/2026 at 20:35, 2 hours 38 minutes ago

RUM Reports Quarterly Financial Results for June 30, 2026

View all ACCESSWIRE

EQS Group

Published on 08/26/2026 at 23:05, 8 minutes ago

Biosidus expands biologics manufacturing capacity and strengthens global supply capabilities for agalsidase beta
Published on 08/26/2026 at 18:44, 4 hours 29 minutes ago

AUSTRIACARD HOLDINGS AG: Press Release H1 2026 Financial Results
Published on 08/26/2026 at 18:40, 4 hours 33 minutes ago

MBC GROUP REVEALS MBC GAMES STUDIO WITH DEBUT TITLE UNVEILING AT GAMESCOM
Published on 08/26/2026 at 18:30, 4 hours 43 minutes ago

Heidelberg Pharma AG and Huadong Medicine Receive NMPA Approval for Clinical Trial of HDP-101 Combination Therapy in China
Published on 08/26/2026 at 18:00, 5 hours 13 minutes ago

MHM Corporate: reduces the nominal value of its shares to €0.011

Les Echos

Published on 08/26/2026 at 18:02, 5 hours 11 minutes ago

Altareit: Altarea press release regarding the Primonial matter
Published on 08/26/2026 at 18:02, 5 hours 11 minutes ago

Altareit : Communiqué de presse d’Altarea relatif au dossier Primonial
Published on 08/26/2026 at 18:00, 5 hours 13 minutes ago

Altarea: Comprehensive settlement agreement reached, ending the dispute between Altarea and the shareholders of the Praemia group (formerly Primonial group)
Published on 08/26/2026 at 18:00, 5 hours 13 minutes ago

Altarea : Conclusion d’un accord global mettant fin au litige entre Altarea et les actionnaires du groupe Praemia (ex-groupe Primonial)
Published on 08/26/2026 at 18:00, 5 hours 13 minutes ago

KLARSEN : lance Dimea, sa nouvelle activité e-commerce dédiée aux compléments alimentaires

View all LES ECHOS COMFI WIRE